EGFR and head and neck squamous cell carcinoma: Once again, IHC analysis performed in pretreatment tumor biopsies from HNSCC patients revealed a beneficial role of high EGFR expression in patients assigned to continuous hyperfractionated accelerated RT (CHART) compared with conventionally-fractionated RT [26].